Trademark: 75919453
Word

Status
Dead
Status Code
710
Status Date
Friday, March 22, 2013
Serial Number
75919453
Registration Number
3130174
Registration Date
Tuesday, August 15, 2006
Mark Type
2000
Filing Date
Wednesday, February 16, 2000
Published for Opposition
Tuesday, May 13, 2003
Cancellation Date
Friday, March 22, 2013

Trademark Owner History
POWER PAPER LTD. - Original Registrant

Classifications
5 Medical, pharmaceutical and health care products, namely, dermatologicals; medicated skin care preparations; adhesive bandages, containing pharmaceuticals for the treatment of-- rosacea, melasma, acne, skin dryness, rash, cellulite, telangiectasia, aging skin, wrinkles, hyperpigmentation, freckles, puffy eyes, scaly skin, couperose, psoriasis, dermatoses, dermatitis, dermatophytosis, ichthyosos, candidiasis, onychomycosis, tinea, tinea unguium, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, warts, scars, keloids, pimples, saborrheic dermatitis for transdermal application and adhesive bandages for transdermally administering pharmaceutical preparations for the treatment of rosacea, melasma, acne, skin dryness, rash, cellulite, telangiectasia, aging skin, wrinkles, hyperpigmentation, freckles, puffy eyes, scaly skin, couperose, psoriasis, dermatoses, dermatitis, dermatophytosis, ichthyosos, candidiasis, onychomycosis, tinea, tinea unguium, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, warts, scars, keloids, pimples and saborrheic dermatitis; medical plasters impregnated with transdermally active pharmaceutical active preparations for the treatment of rosacea, melasma, acne, skin dryness, rash, cellulite, telangiectasia, aging skin, wrinkles, hyperpigmentation, freckles, puffy eyes, scaly skin, couperose, psoriasis, dermatoses, dermatitis, dermatophytosis, ichthyosos, candidiasis, onychomycosis, tinea, tinea unguium, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, warts, scars, keloids, pimples and saborrheic dermatitis; skin patches, for the transdermal delivery of pharmaceuticals, for the treatment of rosacea, melasma, acne, skin dryness, rash, cellulite, telangiectasia, aging skin, wrinkles, hyperpigmentation, freckles, puffy eyes, scaly skin, couperose, psoriasis, dermatoses, dermatitis, dermatophytosis, ichthyosos, candidiasis, onychomycosis, tinea, tinea unguium, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, warts, scars, keloids, pimples and saborrheic dermatitis; adhesive patches for application to the skin for the treatment of rosacea, melasma, acne, skin dryness, rash, cellulite, telangiectasia, aging skin, wrinkles, hyperpigmentation, freckles, puffy eyes, scaly skin, couperose, psoriasis, dermatoses, dermatitis, dermatophytosis, ichthyosos, candidiasis, onychomycosis, tinea, tinea unguium, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, warts, scars, keloids, pimples and saborrheic dermatitis; adhesive patches for medical purposes for the treatment of rosacea, melasma, acne, skin dryness, rash, cellulite, telangiectasia, aging skin, wrinkles, hyperpigmentation, freckles, puffy eyes, scaly skin, couperose, psoriasis, dermatoses, dermatitis, dermatophytosis, ichthyosos, candidiasis, onychomycosis, tinea, tinea unguium, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, warts, scars, keloids, pimples and saborrheic dermatitis; adhesive skin patches for medical use for the treatment of rosacea, melasma, acne, skin dryness, rash, cellulite, telangiectasia, aging skin, wrinkles, hyperpigmentation, freckles, puffy eyes, scaly skin, couperose, psoriasis, dermatoses, dermatitis, dermatophytosis, ichthyosos, candidiasis, onychomycosis, tinea, tinea unguium, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, warts, scars, keloids, pimples and saborrheic dermatitis; adhesive wound, burn and surgical dressings for application to the skin; adhesive wound, burn and surgical dressings for medical purposes; adhesive skin wound, burn and surgical dressings for medical use; wound, burn and surgical dressings incorporating a pharmaceutical preparation for application to the skin for the treatment of dermatological disorders, leg ulcers, pressure sores, lesions, skin grafts, carcinoma and scarring; adhesive medicated dressings incorporating a pharmaceutical preparation for application to the skin for the treatment of tissue retention and support for management of muscle and ligament disorders and injuries, varicose veins, venous insufficiency and limb compression; wound, burn and surgical dressings for the transdermal delivery of pharmaceuticals for the treatment of tissue retention and support for management of muscle and ligament disorders and injuries, varicose veins, venous insufficiency and limb compression; transdermal wound, burn and surgical dressings
The portion of the mark comprised of a plus sign is not displayed in the color red or orange, or in white on a red or orange background, or a colorable imitation thereof. Applicant does not use and will not use the plus sign which appears in its mark in the color red or orange, or in white on a red or orange background, or colorable imitation thereof.

Trademark Events
Mar 22, 2013
Cancelled Sec. 8 (6-Yr)
Aug 15, 2006
Registered-Principal Register
Jun 28, 2006
Law Office Registration Review Completed
Jun 23, 2006
Assigned To Lie
Jun 19, 2006
Allowed Principal Register - Sou Accepted
Jun 10, 2006
Statement Of Use Processing Complete
May 25, 2006
Use Amendment Filed
May 25, 2006
Teas Statement Of Use Received
May 17, 2006
Applicant/Correspondence Changes (Non-Responsive) Entered
Dec 20, 2005
Fax Received
Nov 29, 2005
Noa Mailed - Sou Required From Applicant
Aug 16, 2005
Opposition Terminated No. 999999
Aug 16, 2005
Opposition Dismissed No. 999999
Jan 11, 2005
Teas Response To Office Action Received
Oct 27, 2003
Opposition Instituted No. 999999
Jun 30, 2003
Paper Received
Jun 18, 2003
Extension Of Time To Oppose Received
May 13, 2003
Published For Opposition
Apr 23, 2003
Notice Of Publication
Feb 26, 2003
Approved For Pub - Principal Register
Jan 29, 2003
Correspondence Received In Law Office
Jan 29, 2003
Paper Received
Aug 29, 2002
Final Refusal Mailed
Aug 28, 2002
Assigned To Examiner
May 20, 2002
Correspondence Received In Law Office
Jan 20, 2002
Correspondence Received In Law Office
Jan 28, 2002
Correspondence Received In Law Office
Jul 26, 2001
Non-Final Action Mailed
Jan 29, 2001
Correspondence Received In Law Office
Aug 23, 2000
Non-Final Action Mailed
Jul 17, 2000
Assigned To Examiner
Jul 14, 2000
Assigned To Examiner

Trademark Alertz updated from USPTO on 2030-01-24